This text aims to clarify how to develop and market new drugs efficiently and economically for global markets. It covers the emphasis on over-the-counter drugs in the long-range plans of many companies, and also discusses techniques of institutional review boards (IRBs) and establishment licence applications (ELAs) for biologics in the USA and UK.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Tiber Books, Cockeysville, MD, USA
Hardcover. Zustand: Very Good. . . . . 3rd ed. 8vo, hardcover. No dj. Vg condition. 2 non-circulating ex-lib stamps on 2 early pgs (only markings); contents bright, crisp & clean, virtually unopened. xxxiii, 471 p. Bestandsnummer des Verkäufers 1100306.58
Anzahl: 1 verfügbar
Anbieter: -OnTimeBooks-, Phoenix, AZ, USA
Zustand: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail. Bestandsnummer des Verkäufers OTV.0824703081.G
Anzahl: 1 verfügbar